The 2022 global Cannabidiol (CBD) market reached a size of USD 5.9 Billion and is anticipated to experience a 17% compound annual growth rate (CAGR) in revenue throughout the forecast period. The main drivers of this revenue surge include the increasing adoption of Cannabis for both medical and recreational purposes, as well as the growing utilization of CBD products for therapeutic and medicinal purposes.

The expanding legalization of cannabis for medical and recreational use in numerous countries is another significant factor propelling the revenue growth of the cannabidiol market. This trend is contributing to a heightened demand for CBD products known for their therapeutic and medicinal advantages. Notably, CBD, being a non-psychoactive element of cannabis, ensures that its consumption does not induce a 'high.' Consequently, individuals seeking natural alternatives to prescription medications are displaying a growing interest in CBD products.

Request a sample report of Cannabidiol (CBD) Market @ https://www.reportsanddata.com/download-free-sample/1373

Market Overview:

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Key Players covered in this report are

  • Charlotte's Web Holdings, Inc.
  • Aurora Cannabis Inc.
  • Tilray, Inc.
  • GW Pharmaceuticals, plc.
  • Cannabis Science, Inc.
  • Isodiol International, Inc.
  • Canopy Growth Corporation
  • Elixinol Global Limited
  • Cresco Labs Inc.
  • Medical Marijuana, Inc.

Based on Source Type Outlook is segmented into:

  • CBD Derived from Hemp
  • CBD Derived from Marijuana

Based on Sales Type Outlook is segmented into:

  • Pharmaceuticals
  • Wellness
  • B2B
  • Food & Beverages
  • Personal Care & Cosmetics
  • Nutraceuticals
  • Others
  • B2C
  • By Sales Channel
  • Hospital Pharmacies
  • Online
  • Retail Stores

Based on End-Use Outlook is segmented into:

  • Food And Drink
  • Healthcare
  • Cosmetics
  • Personal Care
  • Others

Read the full report @ https://www.reportsanddata.com/report-detail/cannabidiol-cbd-market

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Major Points covered in this report are as below:

  • An analysis of Cannabidiol (CBD) industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
  • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
  • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
  • This report provides information on the market status of Cannabidiol (CBD) manufacturers and provides valuable insight into the market for companies and individuals.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1373

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report
Comments (0)
No login
Login or register to post your comment